证券之星消息，11月24日南向资金减持6.2万股春立医疗（01858.HK）。近5个交易日中，获南向资金减 持的有4天，累计净减持58.48万股。近20个交易日中，获南向资金增持的有11天，累计净增持124.27万 股。截至目前，南向资金持有春立医疗（01858.HK）4453.41万股，占公司已发行普通股的46.8%。 | 交易日 | 持股总数(股) | 持股变动(股) | 变动幅度 | | --- | --- | --- | --- | | 2025-11-24 | 4453.41万 | -6.20万 | -0.14% | | 2025-11-21 | 4459.61万 | -11.25万 | -0.25% | | 2025-11-20 | 4470.86万 | -13.03万 | -0.29% | | 2025-11-19 | 4483.88万 | -29.52万 | -0.65% | | 2025-11-18 | 4513.41万 | 1.52万 | 0.03% | 北京市春立正达医疗器械股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中 国公司。该公司主要产品为关节假体产品及脊柱类 ...

证券之星消息，11月21日南向资金减持11.25万股春立医疗（01858.HK）。近5个交易日中，获南向资金 减持的有3天，累计净减持38.73万股。近20个交易日中，获南向资金增持的有12天，累计净增持157.45 万股。截至目前，南向资金持有春立医疗（01858.HK）4459.61万股，占公司已发行普通股的46.86%。 北京市春立正达医疗器械股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中 国公司。该公司主要产品为关节假体产品及脊柱类植入产品。关节假体产品涵盖髋、膝、肩、肘四大人 体关节。脊柱类植入产品为脊柱内固定系统的全系列产品组合。该公司的产品出口至亚洲、南美洲、非 洲、大洋洲及欧洲等多个国家和地区。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 | 交易日 | 持股总数(股) | 持股变动(股) | 变动幅度 | | --- | --- | --- | --- | | 2025-11-21 | 4459.61万 | -11.25万 | -0.25% | | 2025-11-20 | 4470.86 ...

Core Viewpoint - Spring Medical experienced a decline of 5.18% on November 21, with a trading volume of 61.44 million yuan and a market capitalization of 9.275 billion yuan [1] Company Overview - Spring Medical is a leading domestic orthopedic medical device manufacturer, focusing on the research, production, and sales of implantable orthopedic medical devices, including oral metal and invisible orthodontics, as well as oral implants and restorations [2][5] - The company is recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which signifies its strong innovation capabilities and high market share in niche markets [3] - The company is located in Tongzhou District, Beijing, and was established on February 12, 1998, with its public listing on December 30, 2021 [7][8] Product and Market Position - Spring Medical's main products include joint prosthetics and spinal implants, covering major human joints such as hip, knee, shoulder, and elbow, along with a full range of spinal internal fixation systems [2][8] - The company has obtained registration certificates for surgical robots for hip and knee joint surgeries, as well as medical image processing software for surgical planning, indicating its investment in smart medical technology [2][3] Financial Performance - For the period from January to September 2025, Spring Medical achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, with a year-on-year increase of 213.21% [8] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [9] Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for Spring Medical was 6,164, an increase of 4.12% from the previous period, while the average circulating shares per person decreased by 3.95% [8] - The stock has seen a net outflow of 4.90 million yuan from major funds today, with a continuous reduction in major fund holdings over the past three days [4][5]

资料显示，北京市春立正达医疗器械股份有限公司位于北京市通州区通州经济开发区南区鑫觅西二路10 号，成立日期1998年2月12日，上市日期2021年12月30日，公司主营业务涉及北京市春立正达医疗器械 股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中国公司。该公司主要产品 为关节假体产品及脊柱类植入产品。关节假体产品涵盖髋、膝、肩、肘四大人体关节。脊柱类植入产品 为脊柱内固定系统的全系列产品组合。该公司的产品出口至亚洲、南美洲、非洲、大洋洲及欧洲等多个 国家和地区。主营业务收入构成为：医疗器械产品99.89%，其他(补充)0.11%。 截至9月30日，春立医疗股东户数6164.00，较上期增加4.12%；人均流通股46906股，较上期减少 3.95%。2025年1月-9月，春立医疗实现营业收入7.56亿元，同比增长48.75%；归母净利润1.92亿元，同 比增长213.21%。 来源：新浪证券-红岸工作室 11月20日，春立医疗跌1.01%，成交额2714.14万元。两融数据显示，当日春立医疗获融资买入额182.68 万元，融资偿还222.02万元，融资净买入-39.34万元。截至11月20 ...

数据显示，中欧基金旗下1只基金位居春立医疗十大流通股东。中欧景气精选混合A（020876）三季度 新进十大流通股东，持有股数283.26万股，占流通股的比例为0.74%。根据测算，今日浮亏损失约 368.24万元。连续6天下跌期间浮亏损失708.15万元。 来源：新浪基金∞工作室 中欧景气精选混合A（020876）成立日期2024年4月23日，最新规模10.52亿。今年以来收益40.41%，同 类排名1394/8136；近一年收益46.46%，同类排名748/8056；成立以来收益56.73%。 11月21日，春立医疗跌5.1%，截至发稿，报24.20元/股，成交4929.49万元，换手率0.69%，总市值92.82 亿元。春立医疗股价已经连续6天下跌，区间累计跌幅8.93%。 中欧景气精选混合A（020876）基金经理为张学明。 资料显示，北京市春立正达医疗器械股份有限公司位于北京市通州区通州经济开发区南区鑫觅西二路10 号，成立日期1998年2月12日，上市日期2021年12月30日，公司主营业务涉及北京市春立正达医疗器械 股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中国公司。该公司 ...

11月19日，春立医疗跌0.73%，成交额3414.26万元。两融数据显示，当日春立医疗获融资买入额403.64 万元，融资偿还707.33万元，融资净买入-303.69万元。截至11月19日，春立医疗融资融券余额合计 5179.45万元。 融资方面，春立医疗当日融资买入403.64万元。当前融资余额5179.45万元，占流通市值的0.70%，融资 余额超过近一年90%分位水平，处于高位。 融券方面，春立医疗11月19日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00 元；融券余量0.00股，融券余额0.00元，超过近一年80%分位水平，处于高位。 来源：新浪证券-红岸工作室 资料显示，北京市春立正达医疗器械股份有限公司位于北京市通州区通州经济开发区南区鑫觅西二路10 号，成立日期1998年2月12日，上市日期2021年12月30日，公司主营业务涉及北京市春立正达医疗器械 股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中国公司。该公司主要产品 为关节假体产品及脊柱类植入产品。关节假体产品涵盖髋、膝、肩、肘四大人体关节。脊柱类植入产品 为脊柱内固定系统的全系列产品组 ...

Group 1 - The core point of the article highlights the recent trading activity of southbound funds in Spring Medical (01858.HK), indicating a net reduction in holdings over the past few days [1] - On November 19, southbound funds reduced their holdings by 29.52 thousand shares, marking a decrease of 0.65% [2] - Over the last 5 trading days, there were 3 days of net reductions totaling 36.65 thousand shares, while in the last 20 trading days, there were 14 days of net increases totaling 251.25 thousand shares [1][2] Group 2 - As of now, southbound funds hold 44.8388 million shares of Spring Medical, which represents 47.12% of the company's total issued ordinary shares [1] - Spring Medical is primarily engaged in the research, production, and sales of implantable orthopedic medical devices, with key products including joint prosthetics and spinal implants [2] - The company's joint prosthetic products cover major human joints such as hip, knee, shoulder, and elbow, while its spinal implant products include a full range of spinal fixation systems [2]

来源：新浪证券-红岸工作室 资料显示，北京市春立正达医疗器械股份有限公司位于北京市通州区通州经济开发区南区鑫觅西二路10 号，成立日期1998年2月12日，上市日期2021年12月30日，公司主营业务涉及北京市春立正达医疗器械 股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中国公司。该公司主要产品 为关节假体产品及脊柱类植入产品。关节假体产品涵盖髋、膝、肩、肘四大人体关节。脊柱类植入产品 为脊柱内固定系统的全系列产品组合。该公司的产品出口至亚洲、南美洲、非洲、大洋洲及欧洲等多个 国家和地区。主营业务收入构成为：医疗器械产品99.89%，其他(补充)0.11%。 截至9月30日，春立医疗股东户数6164.00，较上期增加4.12%；人均流通股46906股，较上期减少 3.95%。2025年1月-9月，春立医疗实现营业收入7.56亿元，同比增长48.75%；归母净利润1.92亿元，同 比增长213.21%。 分红方面，春立医疗A股上市后累计派现3.59亿元。近三年，累计派现3.09亿元。 机构持仓方面，截止2025年9月30日，春立医疗十大流通股东中，香港中央结算有限公司位居第四大流 通股东， ...

Group 1 - The core viewpoint of the articles highlights the recent decline in the stock price of Spring Medical, which has dropped 1.56% to 25.95 CNY per share, with a total market value of 9.954 billion CNY and a cumulative decline of 7.32% over the past four days [1] - Spring Medical is primarily engaged in the research, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants, exporting to various regions including Asia, South America, Africa, Oceania, and Europe [1] - The company's revenue composition is heavily reliant on medical device products, accounting for 99.89% of total revenue, with only 0.11% from other sources [1] Group 2 - According to data, the Fuyong Fund has a significant holding in Spring Medical, with its Fuyong Research Optimal Mixed A Fund holding 64,400 shares, representing 1.8% of the fund's net value, and it ranks as the sixth-largest holding [2] - The Fuyong Research Optimal Mixed A Fund has experienced a year-to-date return of 47.67%, ranking 1019 out of 8140 in its category, and a one-year return of 45.61%, ranking 1043 out of 8057 [2] - The fund manager, Lang Chengcheng, has been in position for 5 years and 127 days, with the fund's total asset size at 1.242 billion CNY, achieving a best return of 61.86% and a worst return of -18.92% during his tenure [3]

来源：新浪基金∞工作室 信澳健康中国混合A（003291）成立日期2017年8月18日，最新规模5.1亿。今年以来收益21.99%，同类 排名4059/8213；近一年收益15.6%，同类排名4646/8130；成立以来收益131.9%。 信澳健康中国混合A（003291）基金经理为李君周、杨珂。 截至发稿，李君周累计任职时间165天，现任基金资产总规模6.34亿元，任职期间最佳基金回报 11.17%， 任职期间最差基金回报10.79%。 杨珂累计任职时间5年190天，现任基金资产总规模13.24亿元，任职期间最佳基金回报43.77%， 任职期 间最差基金回报-13.42%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 11月17日，春立医疗跌4.08%，截至发稿，报26.36元/股，成交9234.63万元，换手率1.19%，总市值 101.11亿元。春立医疗股价已经连续3天下跌，区间累计跌幅5.86%。 资料显示，北京市春立正达医疗器械股份有限公司位于北京市通州区通 ...